Skip to contentNashat Amir — FATE THERAPEUTICS INC insider: 387 transactions · InsiderLensNashat Amir
- Director at Receptos, Inc. · on record since May 14, 2013
- Director at FATE THERAPEUTICS INC · on record since Sep 30, 2013
- 10% owner at FATE THERAPEUTICS INC · on record since Sep 30, 2013
- Director at BIND Therapeutics, Inc · on record since Sep 19, 2013
- Director at CalAmp Corp. · on record since Jun 12, 2026
- 10% owner at CalAmp Corp. · on record since Jun 12, 2026
- Director at Lifeline Systems, Inc. · on record since May 6, 2015
- 10% owner at Lifeline Systems, Inc. · on record since May 6, 2015
- Director at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016
- 10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016
- Director at Cartesian Therapeutics, Inc. · on record since Jun 29, 2016
- 10% owner at Cartesian Therapeutics, Inc. · on record since Jun 29, 2016
- Director at Scholar Rock Holding Corp · on record since May 31, 2018
- 10% owner at Scholar Rock Holding Corp · on record since May 31, 2018
- Director at Morphic Holding, Inc. · on record since Jun 26, 2019
- Director at Metacrine, Inc. · on record since Sep 22, 2020
- 10% owner at Metacrine, Inc. · on record since Sep 22, 2020
Insider trading activity of Nashat Amir
- Transactions on record
- 387
- since May 14, 2013
- Open-market buys
- 26
- $40.7M
- Open-market sells
- 124
- $57.2M
- Companies traded
- 10
- last filing Jun 12, 2026
Figures computed from official regulatory filings — methodology.
Companies where Nashat Amir has traded
- CalAmp Corp.13 tx · $12M · Jun 12, 2026
- Morphic Holding, Inc.36 tx · $12.4M · Aug 20, 2024
- Scholar Rock Holding Corp73 tx · $9.3M · May 13, 2024
- Metacrine, Inc.16 tx · $3M · Sep 6, 2022
- Syros Pharmaceuticals, Inc.14 tx · $5M · Jun 2, 2022
- FATE THERAPEUTICS INC119 tx · $28.7M · Aug 2, 2019
- Cartesian Therapeutics, Inc.55 tx · $9.6M · Jun 18, 2019
- Lifeline Systems, Inc.33 tx · May 17, 2018
- BIND Therapeutics, Inc2 tx · Jun 10, 2015
Track record of Nashat Amir
Statistical track record
Free- Open-market buys
- 28
- Last buy
- Sep 11, 2025
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Nashat Amir
Co-insiders of Nashat Amir
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
26 tx · $28M · Jun 5, 2014
Polaris Venture Partners Founders' Fund V, L.P.BIND Therapeutics, Inc +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 12, 2026 | AwardD | 28,000 | 0.00 USD | $0 | SEC |
| Sep 11, 2025 | Buy | 85,468 | 1.53 USD | $130.8K | SEC |
| Sep 11, 2025 | Buy | 1,221,721 | 1.53 USD | $1.9M | SEC |
| Jun 27, 2025 | AwardD | 9,000 | 0.00 USD | $0 | SEC |
| Oct 15, 2024 | Other | 24,745 | — | — | SEC |
| Oct 15, 2024 | Other | 87,448 | — | — | SEC |
| Oct 15, 2024 | OtherD | -277,536 | — | — | SEC |
| Oct 15, 2024 | Buy | 909,090 | 11.00 USD | $10M | SEC |
| Oct 15, 2024 | Other | 1,250,061 | — | — | SEC |
| Oct 15, 2024 | OtherD | -14,020,475 | — | — | SEC |
| Oct 15, 2024 | OtherD | -980,829 | — | — | SEC |
| Oct 15, 2024 | OtherD | -3,967,234 | — | — | SEC |
| Oct 15, 2024 | Other | 353,718 | — | — | SEC |
| Aug 20, 2024 | OtherD | -17,550 | — | — | SEC |
| Aug 20, 2024 | OtherD | -12,000 | — | — | SEC |
| Aug 20, 2024 | Other | -1,860,498 | — | — | SEC |
| Aug 20, 2024 | OtherD | -24,000 | — | — | SEC |
| Aug 20, 2024 | OtherD | -12,535 | — | — | SEC |
| Aug 20, 2024 | Other | -130,153 | — | — | SEC |
| Aug 20, 2024 | Other | -145 | — | — | SEC |
| Aug 20, 2024 | OtherD | -9,910 | — | — | SEC |
| Aug 20, 2024 | OtherD | -23,168 | — | — | SEC |
| Jun 5, 2024 | AwardD | 23,168 | 0.00 USD | $0 | SEC |
| May 13, 2024 | Other | 276 | 0.00 USD | $0 | SEC |
| May 13, 2024 | Other | -27,606 | 0.00 USD | $0 | SEC |